Advertisement
Sunshine Biopharma, Inc. (SBFM)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 3.0600 |
| Open | 3.0400 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 3.0000 - 3.1899 |
| 52 Week Range | 2.4200 - 660.0000 |
| Volume | |
| Avg. Volume | 168,372 |
| Market Cap | 3.844M |
| Beta (5Y Monthly) | -1.10 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -378.2500 |
| Earnings Date | Nov 11, 2024 - Nov 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 300.00 |
ACCESSWIRESunshine Biopharma Launches Two New Generic Prescription Drugs
FORT LAUDERDALE, FL / ACCESSWIRE / September 26, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals ...
- ACCESSWIRE
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry
Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18% Development of a novel antiviral compound, XR8-23 (Compound 10), targeting SARS-CoV-2 papain-like protease (PLpro) with both submicromolar potency and animal model efficacy ...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.